European shares finish higher; Puma leaps on Anta stake purchase

Reuters01-27
UPDATE 2-European shares finish higher; Puma leaps on Anta stake purchase

Puma shares rise 9% after Anta Sports stake purchase

STOXX 600 up 0.6%, banks lead sectoral gains

HSBC shares hit record high, market value tops $300 billion

Updates with market close

By Niket Nishant, Avinash P and Johann M Cherian

Jan 27 (Reuters) - European equities ended higher on Tuesday, supported by a raft of positive corporate catalysts that eased investor concerns over recent trade tensions, while shares of Puma PUMG.DE jumped after the sportswear maker sold a stake to China's Anta Sports.

The gains underscore how investors are leaning on company-specific factors to guide market sentiment amid an increasingly uncertain macroeconomic environment.

The pan-European STOXX 600 benchmark .STOXX was up 0.6% at 613.11 points and touched its highest in over one week.

Banks .SX7P led sectoral gains with a 1.8% rise and hit their highest since May 2008, with HSBC <HSBA.L> up 2.8% as it briefly hit a $300  billion market value.

"The fundamentals for banks have really improved. We expect loan growth to pick up and we could see further positive earnings surprises from the sector this year," said Ciaran Callaghan, head of European equity research at Amundi.

PUMA CLIMBS, LVMH RESULTS IN FOCUS

Puma's shares rose 9% and hit their highest level since last March, following a deal by Anta Sports Products 2020.HK to buy a 29.06% stake in the German company for 1.5 billion euros ($1.8 billion). The deal is expected to help Puma increase its sales in the lucrative Chinese market.

"At this point in the cycle, we can expect dealmaking to pick up. Balance sheets are strong and management teams are looking to see where incremental growth can come from," Callaghan added.

LVMH LVMH.PA closed up 0.2%. Its U.S.-listed shares were last up 0.4% in choppy trading after the luxury giant said it sold more goods than analysts expected in the fourth quarter, boosting hopes of a luxury sector rebound even as trade tensions, a weaker dollar and high gold prices hit its margins.

Among others, Swiss pharmaceutical firm Roche ROG.S said a phase II clinical trial of its experimental obesity drug CT-388, a once-weekly injection, had delivered positive results. Shares struggled for direction for most of the session and were last flat.

Separately, Indian Prime Minister Narendra Modi said that India and the European Union have finalised a long-pending landmark trade deal, which also included India cutting steep tariffs on automakers.

However, auto stocks .SXAP were down 0.8% as analysts were sceptical about the boost it could give to European brands that are likely to be faced with stiff competition from local carmakers.

Investors are also concerned about the long-term implications of U.S. tariff threats for the global trade order, after U.S. President Donald Trump said he would hike duties on South Korean autos and other imports, citing delays in implementing the pact signed last year.

(Reporting by Niket Nishant, Avinash P and Johann M Cherian in Bengaluru; Editing by Sherry Jacob-Phillips and Shinjini Ganguli)

((Niket.Nishant@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment